MBX Biosciences' Phase 3 hypoparathyroidism trial enrolls, obesity pipeline advancesNov 16Clinical readoutcanvuparatideMBX BiosciencesUpdated
Novo Nordisk posts results for Phase 3 dasiglucagon and liraglutide pediatric trialsNov 16Weekly roundup, 3 itemsliraglutideNovo Nordisk A/S
Altimmune reports Q3 2026 results as pemvidutide programs advance in MASH and AUDNov 12Quarterly updateAltimmune, Inc.MetaVia Inc.
Roche registers giredestrant Phase 3 trial; six other studies updateNov 6Weekly roundup, 16 itemsAbbViealectinibUpdated
IDEAYA completes darovasertib NDA, halts Phase 3 OptimUM-010 for enrollment issuesNov 3Quarterly updateAlector, Inc.Allogene Therapeutics
Amneal raises 2026 guidance on Q3 revenue growth, Kashiv integration progressNov 3Quarterly updateAmneal Pharmaceuticals, LLCXeris Biopharma Holdings, Inc.
Neurocrine posts $1.1 billion quarter, raises INGREZZA sales guidanceNov 2Quarterly updateNeurocrine Biosciencesvalbenazine
Emergent BioSolutions cuts 2026 revenue and EBITDA guidance as Q3 sales fall 52%Nov 2Quarterly updateAmgenAprea Therapeutics
Roche adds Phase III trials in flu prophylaxis and diabetes, plus pediatric SMA study updateOct 22Weekly roundup, 6 itemsbaloxavir marboxilChugai PharmaceuticalUpdated
Viking reports positive maintenance data for obesity drug VK2735Sep 22Clinical readoutViking Therapeutics, Inc.
Kailera reports Q2 2026 results, oral IND active, Phase 2b fully enrolledAug 12Quarterly updateKailera Therapeutics, Inc.
MBX Biosciences reports Q2 2026 results, canvuparatide Phase 3 recruitingAug 6Quarterly updatecanvuparatideMBX Biosciences
Amphastar hits BAQSIMI sales milestone, triggering $100 million payment to LillyAug 6Quarterly updateAmphastar Pharmaceuticals, Inc.Eli Lilly
Amylyx completes LUCIDITY dosing period, sets late-August/early-September readoutAug 6Quarterly updateAmylyx Pharmaceuticals, Inc.avexitide
OPKO reports Q2 2026 results with multiple pipeline milestones across ModeX and OPKO BiologicsJul 27Quarterly updatecalcifediolOPKO Health, Inc.
MetaVia completes dose titration in Phase 1 obesity trial of DA-1726Jul 9Clinical readoutMetaVia Inc.